Proton Therapy Market Size, Share, and Trends 2025 to 2034

The global proton therapy market size accounted for USD 648.64 million in 2025 and is predicted to surpass around USD 1995.62 million by 2034, representing a healthy CAGR of 13.30% between 2025 and 2034. The North America proton therapy market size is calculated at USD 246.18 million in 2024 and is expected to grow at a fastest CAGR of 13.42% during the forecast year.

Last Updated : July 2025  |  Report Code : 2337  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Proton Therapy Market 

5.1. COVID-19 Landscape: Proton Therapy Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Proton Therapy Market, By Product Type

8.1. Proton Therapy Market, by Product Type

8.1.1. Single-Room Proton Therapy Systems

8.1.1.1. Market Revenue and Forecast

8.1.2. Multi-Room Proton Therapy Systems

8.1.2.1. Market Revenue and Forecast

8.1.3. Compact Proton Therapy Systems

8.1.3.1. Market Revenue and Forecast

8.1.4. Modular Proton Therapy Systems

8.1.4.1. Market Revenue and Forecast

Chapter 9. Global Proton Therapy Market, By Component

9.1. Proton Therapy Market, by Component

9.1.1. Accelerators

9.1.1.1. Market Revenue and Forecast

9.1.2. Beam Delivery Systems

9.1.2.1. Market Revenue and Forecast

9.1.3. Imaging and Monitoring Systems

9.1.3.1. Market Revenue and Forecast

9.1.4. Treatment Planning Systems

9.1.4.1. Market Revenue and Forecast

9.1.5. Patient Positioning Systems

9.1.5.1. Market Revenue and Forecast

Chapter 10. Global Proton Therapy Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Product Type

10.1.2. Market Revenue and Forecast, by Component

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Product Type

10.1.3.2. Market Revenue and Forecast, by Component

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Product Type

10.1.4.2. Market Revenue and Forecast, by Component

10.2. Europe

10.2.1. Market Revenue and Forecast, by Product Type

10.2.2. Market Revenue and Forecast, by Component

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Product Type

10.2.3.2. Market Revenue and Forecast, by Component

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Product Type

10.2.4.2. Market Revenue and Forecast, by Component

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Product Type

10.2.5.2. Market Revenue and Forecast, by Component

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Product Type

10.2.6.2. Market Revenue and Forecast, by Component

10.3. APAC

10.3.1. Market Revenue and Forecast, by Product Type

10.3.2. Market Revenue and Forecast, by Component

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Product Type

10.3.3.2. Market Revenue and Forecast, by Component

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Product Type

10.3.4.2. Market Revenue and Forecast, by Component

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Product Type

10.3.5.2. Market Revenue and Forecast, by Component

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Product Type

10.3.6.2. Market Revenue and Forecast, by Component

10.4. MEA

10.4.1. Market Revenue and Forecast, by Product Type

10.4.2. Market Revenue and Forecast, by Component

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Product Type

10.4.3.2. Market Revenue and Forecast, by Component

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Product Type

10.4.4.2. Market Revenue and Forecast, by Component

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Product Type

10.4.5.2. Market Revenue and Forecast, by Component

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Product Type

10.4.6.2. Market Revenue and Forecast, by Component

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Product Type

10.5.2. Market Revenue and Forecast, by Component

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Product Type

10.5.3.2. Market Revenue and Forecast, by Component

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Product Type

10.5.4.2. Market Revenue and Forecast, by Component

Chapter 11. Company Profiles

11.1. IBA Worldwide

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Varian medical systems, Inc

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. HItachi, Ltd

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Mevion medical systems

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Sumitomo Heavy Industries, Ltd

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Optivus Proton Therapy

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Advanced Oncotherapy plc

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. ProTom International

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Mitsubishi Corporation

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. ProNova Solutions LLC

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global proton therapy market size was accounted at USD 572.5 billion in 2024 and it is expected to reach around USD 1995.62 billion by 2034.

The global proton therapy market is poised to grow at a CAGR of 13.30% from 2025 to 2034.

The major players operating in the proton therapy market are IBA Worldwide, Varian medical systems, Inc, HItachi, Ltd, Mevion medical systems, Sumitomo Heavy Industries, Ltd, Optivus Proton Therapy, Advanced Oncotherapy plc, ProTom International, Mitsubishi Corporation, ProNova Solutions LLC, Sun Nuclear Corporation, Provision Healthcare, Koninklijke Philips N.V, Elekta AB, GE Healthcare, Best Cyclotron Systems, Ray Search Laboratories, Permedics

Increasing cancer disorder among the population, rising healthcare spending in developing nations, increased advanced technologies, these are driving factor of the proton therapy market.

North America region will lead the global proton therapy market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client